tiprankstipranks
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF

Defence Therapeutics (DTCFF) Technical Analysis

8 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Defence Therapeutics’s (DTCFF) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Defence Therapeutics is a Sell.
Defence Therapeutics’s (DTCFF) 20-Day exponential moving average is 0.95, while Defence Therapeutics’s (DTCFF) share price is $0.904, making it a Buy.
Defence Therapeutics’s (DTCFF) 50-Day exponential moving average is 1.07, while Defence Therapeutics’s (DTCFF) share price is $0.904, making it a Sell.

Defence Therapeutics (DTCFF) Pivot Points

May 27, 2024, 10:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.79
0.83
0.86
0.89
0.92
0.95
0.99
Fibonacci
0.83
0.85
0.86
0.89
0.91
0.93
0.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Defence Therapeutics (DTCFF) Moving Averages

May 27, 2024, 10:45 AM
Period
Simple
Exponential
MA5
0.90Buy
0.92Buy
MA10
0.93Buy
0.92Buy
MA20
0.93Buy
0.95Buy
MA50
1.06Sell
1.07Sell
MA100
1.29Sell
1.26Sell
MA200
1.64Sell
1.59Sell
Defence Therapeutics’s (DTCFF) 10-Day exponential moving average is 0.92, while Defence Therapeutics’s (DTCFF) share price is $0.904, making it a Buy.
Defence Therapeutics’s (DTCFF) 100-Day exponential moving average is 1.26, while Defence Therapeutics’s (DTCFF) share price is $0.904, making it a Sell.
Defence Therapeutics’s (DTCFF) stock price is $0.904 and Defence Therapeutics’s (DTCFF) 50-day simple moving average is 1.06, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.904 and Defence Therapeutics’s (DTCFF) 100-day simple moving average is 1.29, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.904 and Defence Therapeutics’s (DTCFF) 200-day simple moving average is 1.64, creating a Sell signal.

Defence Therapeutics (DTCFF) Technical Indicators

May 27, 2024, 10:45 AM
Name
Value
Implied Action
RSI (14)
48.97
Neutral
STOCH (9,6)
29.29
Neutral
STOCHRSI (14)
25.45
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
17.25
Buy
Williams %R
-61.70
Buy
CCI (14)
34.03
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
49.73
Neutral
ROC
-7.69
Sell
Defence Therapeutics’s (DTCFF) Relative Strength Index (RSI) is 48.97, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Trend Strength Indicator (ADX) is 17.25, creating a Buy signal.
Defence Therapeutics’s (DTCFF) Commodity Channel Index (CCI) is 34.03, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Price Rate of Change (ROC) is -7.69, creating a Sell signal.

FAQ

Is DTCFF a Buy, Hold, or Sell?
Based on DTCFF’s technical indicators, DTCFF is a Hold.
    What is DTCFF’s RSI (14)?
    DTCFF’s RSI (14) is 48.97, which suggests DTCFF is a Neutral.
      What is DTCFF’s MACD?
      DTCFF’s MACD is -0.04, which suggests DTCFF is a Sell.
        What is DTCFF’s 5-day moving average?
        DTCFF’s 5-day moving average is 0.90, which suggests DTCFF is a Buy.
          What is DTCFF’s 20-day moving average?
          DTCFF 20-day moving average is 0.93, which suggests DTCFF is a Buy.
            What is DTCFF’s 50-day moving average?
            DTCFF’s 50-day moving average is 1.06, which suggests DTCFF is a Sell.
              What is DTCFF’s 200-day moving average?
              DTCFF’s 200-day moving average is 1.64, which suggests DTCFF is a Sell.
                What is DTCFF’s Williams % R (14)?
                DTCFF’s Williams % R (14) is -61.70, which suggests DTCFF is a Buy.
                  What is DTCFF’s CCI (14)?
                  DTCFF’s CCI (14) is 34.03, which suggests DTCFF is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis